nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.791	1	CbGbCtD
Orphenadrine—GRIN2D—hindbrain—amyotrophic lateral sclerosis	0.006	0.0651	CbGeAlD
Orphenadrine—SCN10A—peripheral nervous system—amyotrophic lateral sclerosis	0.00546	0.0592	CbGeAlD
Orphenadrine—GRIN1—hindbrain—amyotrophic lateral sclerosis	0.00535	0.058	CbGeAlD
Orphenadrine—SCN10A—nerve—amyotrophic lateral sclerosis	0.00426	0.0462	CbGeAlD
Orphenadrine—SCN1A—hindbrain—amyotrophic lateral sclerosis	0.0036	0.0391	CbGeAlD
Orphenadrine—GRIN2D—brainstem—amyotrophic lateral sclerosis	0.00344	0.0373	CbGeAlD
Orphenadrine—GRIN1—brainstem—amyotrophic lateral sclerosis	0.00306	0.0332	CbGeAlD
Orphenadrine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00265	0.0287	CbGeAlD
Orphenadrine—GRIN2D—medulla oblongata—amyotrophic lateral sclerosis	0.0024	0.026	CbGeAlD
Orphenadrine—Captodiame—SIGMAR1—amyotrophic lateral sclerosis	0.00228	0.313	CrCbGaD
Orphenadrine—Naftifine—SIGMAR1—amyotrophic lateral sclerosis	0.00223	0.306	CrCbGaD
Orphenadrine—GRIN2D—spinal cord—amyotrophic lateral sclerosis	0.00214	0.0232	CbGeAlD
Orphenadrine—SCN1A—brainstem—amyotrophic lateral sclerosis	0.00206	0.0224	CbGeAlD
Orphenadrine—GRIN1—spinal cord—amyotrophic lateral sclerosis	0.00191	0.0207	CbGeAlD
Orphenadrine—GRIN2D—nervous system—amyotrophic lateral sclerosis	0.0018	0.0195	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—amyotrophic lateral sclerosis	0.00173	0.0188	CbGeAlD
Orphenadrine—GRIN2D—cerebellum—amyotrophic lateral sclerosis	0.00169	0.0184	CbGeAlD
Orphenadrine—GRIN3A—nervous system—amyotrophic lateral sclerosis	0.00169	0.0184	CbGeAlD
Orphenadrine—GRIN3A—central nervous system—amyotrophic lateral sclerosis	0.00163	0.0177	CbGeAlD
Orphenadrine—GRIN1—nervous system—amyotrophic lateral sclerosis	0.00161	0.0174	CbGeAlD
Orphenadrine—GRIN1—central nervous system—amyotrophic lateral sclerosis	0.00155	0.0168	CbGeAlD
Orphenadrine—GRIN1—cerebellum—amyotrophic lateral sclerosis	0.00151	0.0164	CbGeAlD
Orphenadrine—SCN9A—spinal cord—amyotrophic lateral sclerosis	0.00149	0.0162	CbGeAlD
Orphenadrine—SCN1A—medulla oblongata—amyotrophic lateral sclerosis	0.00144	0.0156	CbGeAlD
Orphenadrine—GRIN2D—brain—amyotrophic lateral sclerosis	0.00138	0.0149	CbGeAlD
Orphenadrine—Fluoxetine—SIGMAR1—amyotrophic lateral sclerosis	0.00135	0.184	CrCbGaD
Orphenadrine—GRIN3A—brain—amyotrophic lateral sclerosis	0.00129	0.014	CbGeAlD
Orphenadrine—SCN1A—spinal cord—amyotrophic lateral sclerosis	0.00128	0.0139	CbGeAlD
Orphenadrine—GRIN1—brain—amyotrophic lateral sclerosis	0.00123	0.0133	CbGeAlD
Orphenadrine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00114	0.0123	CbGeAlD
Orphenadrine—SCN10A—spinal cord—amyotrophic lateral sclerosis	0.00114	0.0123	CbGeAlD
Orphenadrine—SCN4A—nervous system—amyotrophic lateral sclerosis	0.00112	0.0122	CbGeAlD
Orphenadrine—SCN1A—nervous system—amyotrophic lateral sclerosis	0.00108	0.0117	CbGeAlD
Orphenadrine—SCN4A—central nervous system—amyotrophic lateral sclerosis	0.00108	0.0117	CbGeAlD
Orphenadrine—SCN1A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.0113	CbGeAlD
Orphenadrine—SCN1A—cerebellum—amyotrophic lateral sclerosis	0.00102	0.011	CbGeAlD
Orphenadrine—SCN9A—brain—amyotrophic lateral sclerosis	0.000961	0.0104	CbGeAlD
Orphenadrine—SCN10A—nervous system—amyotrophic lateral sclerosis	0.000957	0.0104	CbGeAlD
Orphenadrine—SCN10A—central nervous system—amyotrophic lateral sclerosis	0.000922	0.01	CbGeAlD
Orphenadrine—SCN5A—nervous system—amyotrophic lateral sclerosis	0.00087	0.00944	CbGeAlD
Orphenadrine—SCN4A—brain—amyotrophic lateral sclerosis	0.000857	0.0093	CbGeAlD
Orphenadrine—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.000838	0.00908	CbGeAlD
Orphenadrine—SCN1A—brain—amyotrophic lateral sclerosis	0.000827	0.00897	CbGeAlD
Orphenadrine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000793	0.0086	CbGeAlD
Orphenadrine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000742	0.0068	CbGpPWpGaD
Orphenadrine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.000741	0.00803	CbGeAlD
Orphenadrine—SCN10A—brain—amyotrophic lateral sclerosis	0.000732	0.00794	CbGeAlD
Orphenadrine—KCNH2—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.000727	0.00666	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000713	0.00654	CbGpPWpGaD
Orphenadrine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.000713	0.00773	CbGeAlD
Orphenadrine—GRIN1—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000713	0.00653	CbGpPWpGaD
Orphenadrine—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.000712	0.00772	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000694	0.00636	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.000689	0.00631	CbGpPWpGaD
Orphenadrine—Tamoxifen—SIGMAR1—amyotrophic lateral sclerosis	0.00068	0.0931	CrCbGaD
Orphenadrine—GRIN2D—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000679	0.00622	CbGpPWpGaD
Orphenadrine—SCN5A—brain—amyotrophic lateral sclerosis	0.000665	0.00721	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000661	0.00606	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00064	0.00587	CbGpPWpGaD
Orphenadrine—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000635	0.00689	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000619	0.00567	CbGpPWpGaD
Orphenadrine—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000615	0.00563	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000613	0.00562	CbGpPWpGaD
Orphenadrine—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—amyotrophic lateral sclerosis	0.00061	0.00559	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00061	0.00559	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.000597	0.00547	CbGpPWpGaD
Orphenadrine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000596	0.00646	CbGeAlD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000594	0.00544	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000581	0.00533	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000575	0.00527	CbGpPWpGaD
Orphenadrine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000574	0.00622	CbGeAlD
Orphenadrine—CHRM2—brain—amyotrophic lateral sclerosis	0.000566	0.00614	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000566	0.00518	CbGpPWpGaD
Orphenadrine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000548	0.00595	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000539	0.00494	CbGpPWpGaD
Orphenadrine—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000535	0.0058	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000532	0.00487	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000526	0.00482	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000526	0.00482	CbGpPWpGaD
Orphenadrine—Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.000524	0.0717	CrCbGaD
Orphenadrine—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000515	0.00559	CbGeAlD
Orphenadrine—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000503	0.00546	CbGeAlD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000497	0.00456	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000491	0.0045	CbGpPWpGaD
Orphenadrine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000489	0.0053	CbGeAlD
Orphenadrine—GRIN1—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000486	0.00445	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000474	0.00434	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000469	0.0043	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00046	0.00421	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00046	0.00421	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00046	0.00421	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000459	0.0042	CbGpPWpGaD
Orphenadrine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000455	0.00494	CbGeAlD
Orphenadrine—GRIN2D—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000449	0.00412	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000443	0.00406	CbGpPWpGaD
Orphenadrine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000439	0.00476	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000433	0.00397	CbGpPWpGaD
Orphenadrine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000429	0.00465	CbGeAlD
Orphenadrine—GRIN1—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000426	0.00391	CbGpPWpGaD
Orphenadrine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000423	0.00458	CbGeAlD
Orphenadrine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000413	0.00448	CbGeAlD
Orphenadrine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000412	0.00447	CbGeAlD
Orphenadrine—KCNH2—brain—amyotrophic lateral sclerosis	0.000409	0.00443	CbGeAlD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000405	0.00371	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000403	0.00369	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000403	0.00369	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000402	0.00369	CbGpPWpGaD
Orphenadrine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000397	0.0043	CbGeAlD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000395	0.00362	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000395	0.00362	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000395	0.00362	CbGpPWpGaD
Orphenadrine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000388	0.00421	CbGeAlD
Orphenadrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000386	0.00354	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000383	0.00351	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000383	0.00351	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000383	0.00351	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000381	0.00349	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000381	0.00349	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000377	0.00345	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000377	0.00345	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00037	0.00339	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000359	0.00329	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000357	0.00327	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000357	0.00327	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000351	0.00322	CbGpPWpGaD
Orphenadrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000344	0.00315	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000339	0.00311	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000337	0.00309	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000336	0.00308	CbGpPWpGaD
Orphenadrine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000336	0.00364	CbGeAlD
Orphenadrine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000331	0.0036	CbGeAlD
Orphenadrine—HRH1—brain—amyotrophic lateral sclerosis	0.000328	0.00355	CbGeAlD
Orphenadrine—GRIN1—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000322	0.00295	CbGpPWpGaD
Orphenadrine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000319	0.00346	CbGeAlD
Orphenadrine—KCNH2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000317	0.00291	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000316	0.0029	CbGpPWpGaD
Orphenadrine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000315	0.00342	CbGeAlD
Orphenadrine—SCN5A—Cardiac Progenitor Differentiation—IGF1—amyotrophic lateral sclerosis	0.000315	0.00288	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00031	0.00285	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000297	0.00272	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000293	0.00268	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000292	0.00267	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000289	0.00265	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000289	0.00265	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000287	0.00263	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000286	0.00262	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000283	0.00259	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000279	0.00255	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000264	0.00242	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000259	0.00237	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000257	0.00236	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000254	0.00233	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000254	0.00233	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000253	0.00232	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000251	0.0023	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.000241	0.00221	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00024	0.0022	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00024	0.0022	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000238	0.00218	CbGpPWpGaD
Orphenadrine—Fenoprofen—PTGS2—amyotrophic lateral sclerosis	0.000238	0.0325	CrCbGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000232	0.00212	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000215	0.00197	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000214	0.00196	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000208	0.00191	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000205	0.00188	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000204	0.00187	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000204	0.00187	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000204	0.00187	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000204	0.00187	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000198	0.00182	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000197	0.00181	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000197	0.0018	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000193	0.00176	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000183	0.00168	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000183	0.00167	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000179	0.00164	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000176	0.00161	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.000168	0.00154	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000168	0.00154	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.00016	0.00147	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000151	0.00139	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000148	0.00136	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000147	0.00135	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.00014	0.00129	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000131	0.0012	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000127	0.00116	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000119	0.00109	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000119	0.00109	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000118	0.00108	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000117	0.00107	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000105	0.000966	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000102	0.000936	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000101	0.000924	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.0001	0.000917	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.0001	0.000917	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	9.89e-05	0.000907	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	9.52e-05	0.000873	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	9.03e-05	0.000828	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.93e-05	0.000819	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.92e-05	0.000818	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	8.89e-05	0.000814	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.8e-05	0.000806	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.68e-05	0.000795	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	8.66e-05	0.000794	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—MMP9—amyotrophic lateral sclerosis	8.63e-05	0.000791	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.62e-05	0.00079	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.5e-05	0.000779	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	8.4e-05	0.000769	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—MMP9—amyotrophic lateral sclerosis	7.93e-05	0.000727	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	7.75e-05	0.00071	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MMP9—amyotrophic lateral sclerosis	7.65e-05	0.000701	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—MMP9—amyotrophic lateral sclerosis	7.65e-05	0.000701	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	7.12e-05	0.000653	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	6.87e-05	0.000629	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	6.87e-05	0.000629	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.74e-05	0.000618	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.74e-05	0.000618	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	6.6e-05	0.000605	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	6.6e-05	0.000605	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	6.41e-05	0.000587	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MMP9—amyotrophic lateral sclerosis	6.25e-05	0.000573	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.16e-05	0.000565	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	6.16e-05	0.000564	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.04e-05	0.000553	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.73e-05	0.000525	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.66e-05	0.000519	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	5.62e-05	0.000515	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.61e-05	0.000514	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.53e-05	0.000507	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.46e-05	0.0005	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.46e-05	0.0005	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.39e-05	0.000494	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MMP9—amyotrophic lateral sclerosis	5.38e-05	0.000493	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.28e-05	0.000484	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.26e-05	0.000483	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	5.18e-05	0.000474	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	5.1e-05	0.000468	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	5.09e-05	0.000467	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.08e-05	0.000466	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	5.02e-05	0.00046	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.9e-05	0.000449	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.9e-05	0.000449	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	4.87e-05	0.000447	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.83e-05	0.000442	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	4.77e-05	0.000437	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	4.63e-05	0.000425	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	4.56e-05	0.000418	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.47e-05	0.000409	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.46e-05	0.000409	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.01e-05	0.000367	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4e-05	0.000366	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.94e-05	0.000361	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.94e-05	0.000361	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.88e-05	0.000355	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.84e-05	0.000352	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.69e-05	0.000338	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.62e-05	0.000332	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.61e-05	0.000331	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.55e-05	0.000326	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.44e-05	0.000316	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	3.41e-05	0.000312	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.4e-05	0.000311	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.34e-05	0.000306	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	3.34e-05	0.000306	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.22e-05	0.000295	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.17e-05	0.00029	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.12e-05	0.000286	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.07e-05	0.000281	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.06e-05	0.000281	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.06e-05	0.000281	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.8e-05	0.000257	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.8e-05	0.000257	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.77e-05	0.000254	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.74e-05	0.000251	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.74e-05	0.000251	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.72e-05	0.00025	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.69e-05	0.000247	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.6e-05	0.000239	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.45e-05	0.000224	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.29e-05	0.00021	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.25e-05	0.000206	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.23e-05	0.000204	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.21e-05	0.000203	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.19e-05	0.000201	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.02e-05	0.000185	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.99e-05	0.000182	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.88e-05	0.000172	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.85e-05	0.00017	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.76e-05	0.000162	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.74e-05	0.000159	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.68e-05	0.000154	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.68e-05	0.000154	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.65e-05	0.000152	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.55e-05	0.000142	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000138	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.47e-05	0.000135	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.44e-05	0.000132	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.42e-05	0.00013	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000127	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000124	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000124	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.33e-05	0.000122	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.27e-05	0.000117	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.2e-05	0.00011	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.18e-05	0.000108	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000104	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.11e-05	0.000102	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.11e-05	0.000102	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.09e-05	0.0001	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.19e-06	8.43e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.05e-06	8.29e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.79e-06	7.14e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.63e-06	7e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.08e-06	6.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.96e-06	6.38e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.84e-06	6.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.69e-06	6.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.58e-06	6.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.28e-06	5.76e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6e-06	5.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.91e-06	5.42e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.17e-06	4.74e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.54e-06	4.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.46e-06	4.09e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.54e-06	3.25e-05	CbGpPWpGaD
